HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-activity relationship (SAR) of parthenin analogues with pro-apoptotic activity: Development of novel anti-cancer leads.

Abstract
Analogues of parthenin were synthesized by substitutions at different reaction centres to establish a structure-activity relationship (SAR). Some of the molecules have displayed significant cytotoxicity in human cervical carcinoma (HeLa) and human myeloid leukemia (HL-60) cells. A few of the compounds also induced apoptosis in HL-60 cells measured in terms of sub-Go/G1 DNA fraction. Also one of the lead molecules has been shown to be the inhibitor of both telomerase and topoisomerase-II.
AuthorsBhahwal Ali Shah, Rajbir Kaur, Pankaj Gupta, Ajay Kumar, Vijay Kumar Sethi, Samar Singh Andotra, Jaswant Singh, Ajit Kumar Saxena, Subhash Chandra Taneja
JournalBioorganic & medicinal chemistry letters (Bioorg Med Chem Lett) Vol. 19 Issue 15 Pg. 4394-8 (Aug 01 2009) ISSN: 1464-3405 [Electronic] England
PMID19501509 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Sesquiterpenes
  • Topoisomerase II Inhibitors
  • parthenin
  • Telomerase
Topics
  • Antineoplastic Agents (chemical synthesis, pharmacology)
  • Apoptosis
  • Chemistry, Pharmaceutical (methods)
  • Drug Design
  • HL-60 Cells
  • HeLa Cells
  • Humans
  • Inhibitory Concentration 50
  • Models, Chemical
  • Neoplasms (drug therapy)
  • Plasmids (metabolism)
  • Sesquiterpenes (chemical synthesis, pharmacology)
  • Structure-Activity Relationship
  • Telomerase (antagonists & inhibitors)
  • Topoisomerase II Inhibitors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: